Target intelligence / Profile preview

Fimbrial antigen

Molecular classification
Other (surface appendage protein complex), Adhesin, Bacterial surface antigen
01

Overview

Fimbrial antigens are proteinaceous surface appendages (fimbriae or pili) found primarily on Gram-negative bacteria such as Escherichia coli and Salmonella spp[1][4][5]. They are typically much shorter and thinner than bacterial flagella and occur in high numbers on the cell surface. Each fimbrial structure is primarily composed of repeating pilin protein subunits and terminates in specialized adhesive proteins called adhesins, which enable specific binding to glycoprotein receptors on host epithelial cells[3][5][8][9]. This binding is a critical first step in bacterial colonization, allowing pathogens to establish infection at mucosal surfaces (such as the gut, urinary tract, or respiratory tract)[4][7]. Fimbrial antigens are highly immunogenic, able to stimulate strong host immune responses, and are important in the development of vaccines aimed at preventing bacterial infections. Classification schemes for fimbrial antigens are based on morphology, serology, and genetic sequence, with notable subtypes including type 1, F, K88, K99, and colonization factor antigens (CFA/I, CFA/II, etc.)[1][2]. Because their structure shows significant antigenic variation, fimbriae help bacteria evade host immunity, posing a challenge for vaccine development[2][7]. Fimbriae also play roles in aggregation of bacteria and possibly motility. They are not cellular receptors, enzymes, or ion channels but represent a distinct family of bacterial adhesin/antigenic structures. In summary, fimbrial antigens are a diverse group of bacterial surface proteins critical for host adhesion, pathogenesis of infection, and immune recognition, with significant roles as targets for preventive therapies such as vaccines.

Other names
Bacterial fimbrial antigenFimbriaeFimbrial proteinPiliColonization factor antigen (CFA/I, CFA/II, CFA/III)K88 antigenK99 antigenF antigenF piliType 1 fimbrial antigen
02

Mechanism of action

Anti-adhesive vaccines or antibodies: block fimbrial adhesion to the host Antibody-mediated opsonization and clearance Inhibition of colonization factor function Experimental agents may destabilize fimbrial assembly

03

Biological functions

Adhesion to host cellsColonization of epithelial surfacesInitiation of infectionImmune evasion (antigenic variation)Aggregation of bacterial cellsInduction of host immune response
04

Disease associations

InfectionGastrointestinal disease (e.g. diarrheal E. coli)Urinary tract infectionMeningitis (bacterial)GonorrheaOther bacterial diseases where colonization is critical
05

Safety considerations

Antigenic variation: rapid change in fimbrial protein structure can lessen effectiveness of vaccines and antibody therapies[2][7].Potential for cross-reactivity with human tissues (hypothetical, specific evidence lacking)Induction of strong inflammatory or immune response may cause tissue damage
06

Interacting drugs

No conventional small molecules; however, some vaccines (experimental and licensed) target fimbrial antigens, particularly CFA/I and K99 antigens in E. coli[2][7].

2 more in the full profile.

07

Biomarkers

Fimbrial antigens detected by serology or PCR as diagnostic/prognostic markers in infection by specific bacteria (e.g., E. coli K88, K99, CFA/I, F1 fimbrial antigen)[1][3][4].

Beyond the preview

Go deeper on Fimbrial antigen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fimbrial antigen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call